Hot Pursuit     19-Sep-22
Alembic Pharmaceuticals Ltd down for fifth straight session
Alembic Pharmaceuticals Ltd is quoting at Rs 608.2, down 0.28% on the day as on 13:19 IST on the NSE. The stock tumbled 34.24% in last one year as compared to a 1.29% rally in NIFTY and a 12.82% fall in the Nifty Metal index.

Alembic Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quoting at Rs 608.2, down 0.28% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.51% on the day, quoting at 17620.7. The Sensex is at 59118.57, up 0.47%.Alembic Pharmaceuticals Ltd has lost around 6.39% in last one month.Meanwhile, Nifty Metal index of which Alembic Pharmaceuticals Ltd is a constituent, has eased around 2.37% in last one month and is currently quoting at 12346.85, down 0.46% on the day. The volume in the stock stood at 55341 shares today, compared to the daily average of 1.11 lakh shares in last one month.

The PE of the stock is 17.82 based on TTM earnings ending June 22.

Previous News
  Stock Alert: Alembic Pharma, Bajel Projects, Zydus Lifesciences, Lupin, Adani Enterprises, Biocon
 ( Market Commentary - Stock Alert 30-Sep-24   08:34 )
  Alembic Pharma gets USFDA nod for Betamethasone Valerate Foam
 ( Hot Pursuit - 24-Aug-24   16:59 )
  Alembic Pharmaceuticals receives USFDA approval for Betamethasone Valerate Foam
 ( Corporate News - 24-Aug-24   14:03 )
  Alembic Pharma hits record high on USFDA nod for anti psychotic drug
 ( Hot Pursuit - 24-Jul-24   14:43 )
  Alembic Pharma gets US FDA nod for heart failure-treatment drug
 ( Hot Pursuit - 30-May-24   14:05 )
  Alembic Pharma gets USFDA nod for stroke and blood clots drug
 ( Hot Pursuit - 18-Jun-24   14:27 )
  Alembic Pharmaceuticals AGM scheduled
 ( Corporate News - 06-Jun-23   18:21 )
  CRISIL reaffirms ratings of Alembic Pharmaceuticals with 'stable' outlook
 ( Hot Pursuit - 08-Mar-24   11:22 )
  Alembic Pharma reports turnaround Q1 numbers
 ( Hot Pursuit - 05-Aug-23   12:56 )
  Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
 ( Corporate News - 18-Jun-24   18:52 )
  Alembic Pharmaceuticals receives USFDA approval for Sacubitril and Valsartan Tablets
 ( Corporate News - 30-May-24   14:49 )
Other Stories
  Tata Motors total sales drop 11% YoY in Sept’24
  01-Oct-24   15:33
  Vipul Organics hits all-time high after board OKs Rs 25 cr right issue
  01-Oct-24   15:06
  Magellanic Cloud Ltd leads losers in 'A' group
  01-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  01-Oct-24   14:45
  GE Power India rises on bagging order worth Rs 240-cr
  01-Oct-24   14:41
  Volumes jump at Caplin Point Laboratories Ltd counter
  01-Oct-24   14:30
  TVS Motor registers 20% growth in September 2024 sales; Q2 total sales at 12.28 lakh units
  01-Oct-24   14:07
  Oil and Gas shares slide
  01-Oct-24   14:00
  Telecom shares fall
  01-Oct-24   14:00
  Real Estate stocks slide
  01-Oct-24   14:00
Back Top